Appointment of Lisa Dolovich as Dean of the Leslie Dan Faculty of Pharmacy (PDAD&C #44)
From: Cheryl Regehr, Vice-President & Provost
Date: February 28, 2020
Re: Appointment of Lisa Dolovich as Dean of the Leslie Dan Faculty of Pharmacy (PDAD&C #44)
I am delighted to announce that the Agenda Committee of Academic Board has approved the appointment of Professor Lisa Dolovich as Dean of the Leslie Dan Faculty of Pharmacy for a five-year term beginning July 1, 2020.
Professor Lisa Dolovich currently serves as the Interim Dean at the Leslie Dan Faculty of Pharmacy. Professor Dolovich’s keen insights and collaborative style have helped to stabilize the Faculty during a period of transition. At the same time, her concerted efforts to bring faculty, staff, and students together to discuss, plan, and implement changes, have moved important priorities forward. During the past six months as Interim Dean, Professor Dolovich’s accomplishments include striking a committee to review the Faculty’s workload policy, leading the Faculty’s strategic planning process, and bringing together members of the Pharmacy community to discuss priorities and plans for the future of the field and the profession. Professor Dolovich’s ability to build consensus and move forward in a collegial manner has had a significant and positive impact across the Faculty.
Professor Dolovich is an internationally recognized scholar distinguished for her work on how individuals manage their medicine and health in the context of where they live. Her research expertise on the scope of services offered by pharmacists is particularly relevant to ongoing discussions and changes in the pharmacy profession, and will be key to the Faculty’s continued success in the coming years. Professor Dolovich has contributed to the publication of more than 200 peer-reviewed publications, has held more than $5 million in grants from the Canadian Institute of Health Research (CIHR) as a Principal Investigator, over 26 million dollars from the CIHR as a co-investigator, and has served on the executive committee of the CIHR health management and policy project grants review for the past six cycles. Professor Dolovich has been a lead of several impactful research programs, such as the Cardiovascular Health Awareness Program, which was recognized as a Top Canadian Achievement in Health Research in 2013. She is also the co-founder of the Ontario Pharmacy Evidence Network, a multi-institutional and interdisciplinary research program aimed at providing high-quality evidence for use by governments, patients, and healthcare providers.
Professor Dolovich’s leadership skills and administrative experience will be crucial to furthering the Faculty’s excellence in the years ahead. Please join me in congratulating Professor Dolovich on her appointment as Dean.